Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Immune infiltration, effector T-cell enrichment, and functional context for prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer
Authors:ID Demšar, Ana (Author)
ID Geršak, Klara (Author)
ID Gazić, Barbara (Author)
ID Blagus, Tanja (Author)
ID Goričar, Katja (Author)
ID Jezernik, Gregor (Author)
ID Dolžan, Vita (Author)
ID Grašič-Kuhar, Cvetka (Author)
Files:URL URL - Source URL, visit https://pmc.ncbi.nlm.nih.gov/articles/PMC12985902/pdf/ijms-27-02431.pdf
 
.pdf PDF - Presentation file, download (23,29 MB)
MD5: FDE143CA2792ED54B8372C5DD75A4386
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Abstract:Tumor-infiltrating lymphocytes (TILs) are an established predictor of pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) in breast cancer. However, TILs primarily reflect the extent of immune infiltration and provide limited insight into immune functional state. We investigated whether integrating measures of immune infiltration (TILs), effector T-cell presence (CD8), and functional context (immune checkpoint components) may improve prediction of pCR beyond TILs alone. Pretreatment tumor biopsies from 166 patients with early breast cancer treated with standard NACT were assessed for stromal TILs and mRNA expression of CD8, PD-1, LAG-3, and TIM-3. Associations with pCR were evaluated using univariate and multivariable logistic regression, and composite immune phenotypes were constructed to capture functional immune states. In univariate analyses, higher TILs, CD8, PD-1, and LAG-3 were associated with pCR (all p < 0.05), whereas TIM-3 was not (p = 0.801). In multivariable models, TILs remained independently associated with pCR when adjusted for checkpoint markers, but this association was attenuated when CD8 was included, consistent with the strong biological correlation between TILs and CD8, and neither CD8 nor checkpoint markers retained independent significance. PD-1 and LAG-3 expression strongly correlated with CD8 and moderately correlated with TILs, indicating that checkpoint expression predominantly reflects an immune effector-engaged tumor microenvironment. Composite immune phenotypes based on CD8/PD-1 co-expression identified distinct immune functional states, with CD8-high/PD-1-high tumors demonstrating the highest pCR rates. Hierarchical modeling showed modest improvements in discrimination with sequential addition of immune variables to clinical predictors, with the integrative CD8/PD-1 model achieving the highest discrimination within the cohort (AUC = 0.849), although the magnitude of improvement beyond TIL assessment alone was limited. In conclusion, immune infiltration, effector T-cell presence, and functional immune context represent complementary dimensions for pCR prediction following NACT in breast cancer. However, TILs remain the most robust and clinically feasible immune biomarker.
Keywords:PD-1 immune checkpoint, breast cancer, immune microenvironment, neoadjuvant chemotherapy
Publication status:Published
Publication version:Version of Record
Submitted for review:31.01.2026
Article acceptance date:04.03.2026
Publication date:06.03.2026
Place of publishing:Basel
Publisher:MDPI, Basel, Switzerland
Year of publishing:2026
Number of pages:str. 1- 2431-18- 2431
Numbering:Vol. 27, no. 5
Source:Basel, Switzerland
PID:20.500.12556/DiRROS-29053 New window
UDC:618.1
ISSN on article:1422-0067
DOI:10.3390/ijms27052431 New window
COBISS.SI-ID:273921795 New window
Copyright:by Authors
Note:Nasl. z nasl. zaslona; Opis vira z dne 19. 3. 2026;
Publication date in DiRROS:20.04.2026
Views:112
Downloads:67
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0321-2020
Name:Napovedni dejavniki poteka bolezni in odgovora na zdravljenje pri različnih vrstah raka

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0289-2019
Name:Značilnosti malignih neoplazem, pomembne za diagnozo ter napoved poteka bolezni in izida zdravljenja

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:imunski inhibitor PD-1, rak dojke, imunsko mikrookolje, neoadjuvantna kemoterapija


Back